The current CYCC market cap is 1.84M. The company's latest EPS is USD -25.3887 and P/E is -0.08.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 373k | 16k |
Operating Income | -6.47M | -8.85M | -7.32M | -5.93M | -6.85M |
Net Income | -5.15M | -7.47M | -5.85M | -5.5M | -6.08M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 150k | 0 | 0 | 0 | 0 |
Operating Income | -9.55M | -9.68M | -10.64M | -22.94M | -27.66M |
Net Income | -7.49M | -8.03M | -12.42M | -19.09M | -21.4M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 31.02M | 27.5M | 22.06M | 16.44M | 12.5M |
Total Liabilities | 4.46M | 7.5M | 7.42M | 6.81M | 8.2M |
Total Equity | 22.07M | 15.51M | 10.15M | 5.14M | 4.3M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 19.82M | 15.31M | 36.8M | 42.59M | 27.5M |
Total Liabilities | 4.55M | 3.61M | 3.54M | 5.32M | 7.5M |
Total Equity | 15.27M | 11.7M | 33.26M | 37.26M | 15.51M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -15.66M | -20.83M | -6.86M | -8.17M | -12.2M |
Investing | -7k | -7k | -6k | -6k | -6k |
Financing | 2.96M | 3M | -50k | -101k | -151k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.7M | -9.45M | -7.93M | -18.54M | -20.83M |
Investing | -39k | 28k | -96k | -27k | -7k |
Financing | 429k | 3.85M | 29.5M | 21.74M | 3M |
Market Cap | 1.84M |
Price to Earnings Ratio | -0.08 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.1 |
Price to Book Ratio | 0.09 |
Dividend Yield | - |
Shares Outstanding | 842.86k |
Average Volume (1 week) | 47.63k |
Average Volume (1 Month) | 40.04k |
52 Week Change | -75.37% |
52 Week High | 13.20 |
52 Week Low | 1.8201 |
Spread (Intraday) | 0.07 (3.18%) |
Company Name | Cyclacel Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.cyclacel.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.